Masimo Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Katie Szyman
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 6yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Masimo: Priced Dearly Given Uncertainty
Apr 25Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now
Apr 24
An Intrinsic Calculation For Masimo Corporation (NASDAQ:MASI) Suggests It's 34% Undervalued
Feb 17At US$178, Is Masimo Corporation (NASDAQ:MASI) Worth Looking At Closely?
Jan 30Masimo: A Stellar Performance After The Dust Has Settled
Dec 11Here's Why Masimo (NASDAQ:MASI) Has A Meaningful Debt Burden
Nov 28Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation?
Nov 07Masimo Corporation's (NASDAQ:MASI) 28% Share Price Surge Not Quite Adding Up
Oct 15Masimo Corporation: Too Much Uncertainty For Now
Sep 25
Sensors Surge And Decisive Shifts Set To Soar In Healthcare Triumph
Aug 28 Increased hospital admissions and successful hospital conversions to Masimo products are anticipated to continue driving healthcare revenue growth.What Is Masimo Corporation's (NASDAQ:MASI) Share Price Doing?
Aug 01Masimo Corporation's (NASDAQ:MASI) Share Price Matching Investor Opinion
Jul 11These 4 Measures Indicate That Masimo (NASDAQ:MASI) Is Using Debt Extensively
Jun 19Masimo: Promising Developments
May 12Analyst Estimates: Here's What Brokers Think Of Masimo Corporation (NASDAQ:MASI) After Its First-Quarter Report
May 10Baron Funds - Masimo Corp.: Can Potentially Double Our Investment
May 05Masimo: Given The Lack Of Improvement In Revenues And Margins, It Is A Little Expensive
Feb 18CEO
Katie Szyman (57 yo)
less than a year
Tenure
Ms. Catherine M. Szyman, also known as Katie, serves as Chief Executive Officer at Masimo Corporation since February 12, 2025. She is an Independent Director of Inari Medical, Inc. since November 25, 2019....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | no data | |
| Executive VP & CFO | 7.6yrs | US$8.12m | 0.032% $ 2.9m | |
| Chief Operating Officer | 6yrs | US$8.18m | 0.045% $ 4.0m | |
| Chief Operating Officer of Consumer Division | 2.7yrs | US$6.85m | 0.016% $ 1.4m | |
| Senior VP & Chief Accounting Officer | 2.3yrs | no data | no data | |
| Executive VP & Chief Information Officer | 23.1yrs | US$1.49m | no data | |
| Chairman of Scientific Advisory Board & Chief Science Officer | 10.2yrs | US$139.56k | no data | |
| Vice President of Business Development & Investor Relations | 15.9yrs | no data | no data | |
| Executive Vice President of Operations & Clinical Research | 6yrs | US$1.97m | no data | |
| President of Masimo Japan | no data | no data | no data |
6.0yrs
Average Tenure
53.5yo
Average Age
Experienced Management: MASI's management team is seasoned and experienced (6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | no data | |
| Chairman of Scientific Advisory Board & Chief Science Officer | no data | US$139.56k | no data | |
| Independent Director | less than a year | US$227.89k | no data | |
| Director | less than a year | no data | no data | |
| Lead Independent Director | 11.1yrs | US$330.41k | 0.031% $ 2.7m | |
| Independent Director | less than a year | US$215.17k | no data | |
| Independent Director | less than a year | US$215.97k | no data | |
| Independent Director | 1.3yrs | US$484.30k | 0.032% $ 2.8m | |
| Independent Director | less than a year | US$226.01k | no data | |
| Independent Vice-Chairman | 1.9yrs | US$300.89k | 0.0045% $ 402.2k | |
| Independent Chairman | 1.9yrs | US$2.62m | 0.0098% $ 871.7k |
0.7yrs
Average Tenure
65yo
Average Age
Experienced Board: MASI's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/02 05:33 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/28 |
| Annual Earnings | 2024/12/28 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Masimo Corporation is covered by 31 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Ishan Majumdar | Baptista Research |
| Charley Jones | Barrington Research Associates, Inc. |